Autopsy report · NCT00372489

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Due to more robust long-term data generated in other active-controlled studies”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 years 2 months before it stopped.
81 participants enrolled.
Results were posted on the registry 2 years 6 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Affymax
Sponsor type: Industry
Conditions: Chronic Renal Failure; Chronic Kidney Disease; Anemia
Interventions: peginesatide
Participants: 81
Sites: 9
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.